Travoprost 3-Month Safety and Efficacy Study

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2011
The purpose of this study was to demonstrate that the intraocular pressure-lowering efficacy of Travoprost 0.003% is equivalent to TRAVATAN® in adult patients with open-angle glaucoma or ocular hypertension.
Epistemonikos ID: 81dea9573c6fd43d9b7d540376f6a928849cd118
First added on: May 10, 2024